Skip to main content
nl
fr
en
Get to know Sciensano
About Sciensano
Sciensano in figures
Sciensano's structure
Contact Sciensano
Our commitment to quality, health, safety and environment
Partnerships
Emergency and Response
Working / doing an internship at Sciensano
Jobs
Values and standards
History of Sciensano
2022 Annual report
Areas of expertise
List of health topics from A-Z
Health and disease monitoring
Animal Health
Effectiveness of safety of vaccines, medicines and health products - Quality of medical laboratories
Food consumption and food safety
Health and environment
Quality of healthcare
Our services
Analysis request
Data collection
External quality assessment
Control and Safety Assessment
Licensing
Health Information
Health Threats
Projects
Reports & Publications
Press Corner
Search form
Search
Home
Projects
PartnERship to Contrast HPV (PERCH)
An interdisciplinary strategy to identify medical devices as a source of allergic or pyrogenic reactions (QMED)
Exploring the person-centredness of the Investigation to reveal the immune reaction upon COVID-vaccination in the Belgian cancer population: COVID protection and Vaccine safety study (REAL-V )
National infrastructure for genomic-epidemiologic surveillance of infectious diseases (HERA-BE-Incubator-2021)
Innovations to accelerate vaccine development vaccine development and manufacture (INNO4VAC)
Development of shotgun METAgenoMics apprOaches in suppoRt of Public Health fOr the next Sequencing Era (METAMORPHOSE)
Identification, physicochemical characterisation and estimation of release of titanium dioxide particles from face masks applied during the COVID-19 crisis in view of risk analysis (TiO2Mask)
3-dimensional chromatographic approaches for screening of regulated plants in plant food supplements (3D-herbs)
Monitoring of the whole genome sequencing (WGS) data of SARS-CoV-2 genomes to identify variants and their impact on detection methods (COVIPRIM_VAR2)
Development of a method to assess the diversity of SARS-CoV-2 circulating strains in Belgium (COVIDDIVER)
Development of a digital PCR method for accurate detection and quantification of SARS-CoV-2 (DIGICOVID)
Development of a digital PCR method for accurate detection and quantification of SARS-CoV-2 and its variants (DIGICOVID_VAR)
Address and Reduce Drug Use of Inmates and Ex-inmates through Data Analysis and Intervention Programs (PRS20)
Linking of registers for COVID-19 vaccine surveillance (LINK-VACC)
Understanding the dynamics and consequences of new psychoactive substances use in a rapidly changing (online) drug market (SCANNER)
Monitoring the performance of detection methods for SARS-CoV-2 in clinical samples using sequencing data (COVIPRIM)
Evaluation of the types, efficient use and health risks of application of silver-based biocides to provide antimicrobial properties to face masks applied during the COVID-19 crisis (AgMask)
Development of innovative methodological approaches for the study of complex samples: application to the analysis of cannabis and derived products (CANNAL)
The Belgian Survey on Drugs (DrugVibes)
Characterisation and risk evaluation of CBD products on the Belgian market (CBD-RISK)
Problematic drug use and infectious diseases in Brussels (Belgium) (Push)
Safety assessment of feminine intimate products (FEMINA)
Optimisation of virological and serological diagnosis as part of avian influenza monitoring in preparation for the emergence of new highly pathogenic (HP) viruses (EMERDIAH5)
Evaluation of important aspects of the efficacy of inactivated and live attenuated lumpy skin disease vaccines for cattle (GALVmed LSD)
Characterisation and risk evaluation of counterfeit antibiotics on the European market (counterfeit antibiotics)
Comparing vaccines, batch by batch, by performing consistency tests (VAC2VAC)
Transversal platform of Biotechnology and Molecular Biology (BIOTECH Platform)
Lumpy skin disease in Belgian cattle and potential vectors: risk assessment, diagnosis, control, vaccination, transmission and vector competence studies to prevent the introduction and spread (RCO LUMPY SKIN)
Towards a toxicologically relevant definition of nanomaterials (To²DeNano)
Characterisation and risk evaluation of electronic cigarettes and related products (e-SMOKE)
Personalized Medicine: introduction of Next-Generation-Sequencing in Routine diagnostics in (hemato) oncology in Belgium (canc-NGS)
Characterisation of a rod-shaped TiO2 candidate reference material using transmission electron microscopy (TEM) (Nanorod)
Host response gene signatures associated with FMDV infection, vaccination and persistence (TRANSCRIPTOVAC)
Zoonoses Anticipation and Preparedness Initiative (ZAPI)
Illegal peptides and proteins (ILPEP)
Development of new adjuvants for tuberculosis vaccines (TBVAC2020)
Development of an integrated approach based on validated and standardised methods to support the implementation of the EC recommendation for a definition of nanomaterial (NanoDefine )
Accelerated Development of Vaccine Benefit-Risk Collaboration in Europe (ADVANCE)
Use of proteomics for the quality control of intravenous immunoglobulins (PLPROT)
Virus-host interplay at the early stages of infection (BELVIR)
Belgian Treatment Demand Indicator Register (BTDIR)
Network of pediatric infectious disease surveillance (PediSurv)
Belgian Early Warning System on Drugs (BEWSD)
Animal health
Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories
Food consumption and food safety
Health and disease monitoring
Health and environment
Quality of healthcare
QR code
